GlassScriptPhysician profile
Basharat Ahmad
NPI 1346777638
$5,758.23
in general payments reported to CMS, 2019-2025
10 companies · $4,644 in 2025
The $4,644 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.65 · 2024: $1,095 · 2025: $4,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,067 · Grant: $1,063 · Travel and Lodging: $958 · Food and Beverage: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,066.78 |
| Grant | $1,063.30 |
| Travel and Lodging | $957.76 |
| Food and Beverage | $670.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,066.78 | 2025 | |
| Boston Scientific Corporation | $1,148.82 | 2024-2025 | General - Vascular Access, Avvigo Guidance System, Farapulse |
| Philips North America LLC | $1,032.18 | 2025 | Igt Devices Undivided |
| Abiomed | $216.65 | 2025 | |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Novo Nordisk INC | $50.00 | 2025 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.00 | 2025 | Lifevest |
| Terumo Medical Corporation | $18.65 | 2023 | Angio-Seal |
| Sanofi-Aventis U.S. LLC | $17.29 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.86 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basharat Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.